logo

Nanovibronix, Inc. (NAOV)



Trade NAOV now with
  Date
  Headline
5/17/2022 8:33:34 AM NanoVibronix Q1 Revenue Of $272,000, Increase Of 164% From Prior Year
5/4/2022 8:40:00 AM NanoVibronix Announces FDA 510(k) Submission For PainShield MD PLUS
12/21/2021 8:06:41 AM NanoVibronix Announces Agreement With Medina Healthcare For Distribution Of UroShield And PainShield In Europe
11/16/2021 8:36:43 AM NanoVibronix Q3 Revenue Of $499,000, Increase Of 233% From Prior Year
7/26/2021 10:53:09 AM NanoVibronix Says Ships First Order Of PainShield Plus
4/19/2021 9:55:11 AM NanoVibronix Announces Start Of Real World Patient Study Of UroShield
2/3/2021 8:12:01 AM NanoVibronix Regains Nasdaq Compliance